Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,112.00
Bid: 12,112.00
Ask: 12,114.00
Change: 84.00 (0.70%)
Spread: 2.00 (0.017%)
Open: 12,036.00
High: 12,114.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazil eyes July for full local production of AstraZeneca vaccine

Mon, 15th Mar 2021 18:32

By Rodrigo Viga

RIO DE JANEIRO, March 15 (Reuters) - Brazil could begin full
production of AstraZeneca Plc's COVID-19 vaccine by July
if regulators allow, an official at biomedical center Fiocruz
said, moving up by 100 days the timeline to produce shots
without imported ingredients.

Fiocruz Vice President Marco Krieger told Reuters that, if
health regulator Anvisa waives some controls, the biomedical
institute could move up the Sept. 30 target date for 100% local
production of the shot by AstraZeneca and Oxford University.

"This would be important at a time when Brazil is facing
vaccine shortages," Krieger said in an interview on Friday.

Delays in getting supplies from India and China have slowed
Fiocruz's finishing line and Brazil's vaccination program. Only
6% of Brazil's adult population has had their first of two
shots.

Federally funded Fiocruz, based in Rio de Janeiro, has
delivered 4 million ready-made vaccines from India and is
filling and finishing shots with active ingredients from China.
Delivery of those doses, starting this week, is expected to
total 100.4 million by July.

Fully local production of the vaccine is scheduled for
September, when Fiocruz plans to start delivery of 110 million
doses for Brazil's immunization program.

Given the urgent need for vaccines in Brazil, which lost
more than 12,000 lives to the pandemic last week alone, Krieger
said he hoped Anvisa would help to shorten that timeline.

As the vaccine is already in use in Europe and elsewhere,
Krieger said Fiocruz may be able to get Anvisa's approval after
the regulator supervises production of just one batch, rather
than the customary three batches.

Along with the 4 million AstraZeneca doses, Brazil's
government has received 20.6 million doses of CoronaVac, made by
China's Sinovac Biotech Ltd and bottled by Sao Paulo's
Butantan Institute with active ingredients from China.

On Friday, Anvisa granted final approval for AstraZeneca's
vaccine. CoronaVac has been approved for emergency use.

Krieger said output from Fiocruz should reach 1 million
doses a day by the end of March. By then, Fiocruz will have
received another shipment of ingredients from China to make 30
million doses, he said.

Krieger did not address the British vaccine being halted
last week in Denmark, Norway and Iceland over bleeding and
clotting issues.

AstraZeneca said on Sunday a review of safety data of people
vaccinated with its COVID-19 vaccine has shown no evidence of
increased risk of blood clots.
(Reporting by Rodrigo Viga Gaier
Writing by Anthony Boadle; Editing by Richard Chang)

More News
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.